Fabrinet shares slide as investors digest recent earnings guidance and valuation concerns

Fabrinet (FN) is down 5.8% today. Here is some analysis on what might have caused this price movement.

Analysis: The drop appears tied to continued post-earnings positioning after Fabrinet’s recent quarterly report, where results were strong but the forward outlook may have been viewed as less of an upside surprise than the market had priced in. With the stock having traded at a premium valuation, even “in-line” guidance can trigger profit-taking. An earlier high-profile analyst downgrade also may still be weighing on sentiment.

Details:

Fabrinet reported fiscal third-quarter 2026 results for the period ended March 27, 2026, including GAAP diluted EPS of $3.45 (up from $2.25 a year earlier).

For the following quarter ending June 26, 2026, the company guided revenue to $1.25 billion–$1.29 billion (with a GAAP-to-non-GAAP reconciliation provided in the release materials).

Recent trading action suggests investors are recalibrating expectations after the earnings release, particularly around how much incremental acceleration is likely in the next quarter.

Separately, a major bank lowered its rating in mid-April 2026, which can amplify downside moves when momentum cools.

Sources:

U.S. SEC (EDGAR), Nasdaq, Fintel

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$FN Insider Trading Activity

$FN insiders have traded $FN stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $FN stock by insiders over the last 6 months:

SEAMUS GRADY (Chief Executive Officer) has made 0 purchases and 4 sales selling 22,451 shares for an estimated $10,034,497.
THOMAS F KELLY has made 0 purchases and 5 sales selling 4,050 shares for an estimated $2,175,243.
HOMA BAHRAMI sold 3,500 shares for an estimated $1,588,114
DARLENE S. KNIGHT has made 0 purchases and 2 sales selling 1,000 shares for an estimated $477,056.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$FN Hedge Fund Activity

We have seen 324 institutional investors add shares of $FN stock to their portfolio, and 261 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

PRICE T ROWE ASSOCIATES INC /MD/ added 2,504,841 shares (+163.0%) to their portfolio in Q4 2025, for an estimated $1,140,404,010
POINT72 ASSET MANAGEMENT, L.P. removed 465,312 shares (-59.6%) from their portfolio in Q4 2025, for an estimated $211,847,247
CITADEL ADVISORS LLC removed 432,283 shares (-71.0%) from their portfolio in Q4 2025, for an estimated $196,809,804
JPMORGAN CHASE & CO added 419,081 shares (+64.8%) to their portfolio in Q4 2025, for an estimated $190,799,197
CAPITAL INTERNATIONAL INVESTORS removed 337,584 shares (-52.9%) from their portfolio in Q4 2025, for an estimated $153,695,243
CAPITAL RESEARCH GLOBAL INVESTORS removed 297,162 shares (-29.5%) from their portfolio in Q4 2025, for an estimated $135,291,915
HAWK RIDGE CAPITAL MANAGEMENT LP removed 276,395 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $125,837,115

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$FN Congressional Stock Trading

Members of Congress have traded $FN stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $FN stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $50,000 on 03/27.
REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 03/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$FN Analyst Ratings

Wall Street analysts have issued reports on $FN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Rosenblatt issued a "Buy" rating on 02/03/2026
Needham issued a "Buy" rating on 02/03/2026

To track analyst ratings and price targets for $FN, check out Quiver Quantitative's $FN forecast page.

$FN Price Targets

Multiple analysts have issued price targets for $FN recently. We have seen 6 analysts offer price targets for $FN in the last 6 months, with a median target of $691.0.

Here are some recent targets:

Tim Long from Barclays set a target price of $702.0 on 05/06/2026
Ryan Koontz from Needham set a target price of $800.0 on 05/05/2026
Mike Genovese from Rosenblatt set a target price of $750.0 on 05/05/2026
Samik Chatterjee from JP Morgan set a target price of $680.0 on 05/05/2026
Dave Kang from B. Riley Securities set a target price of $452.0 on 02/03/2026
Christopher Rolland from Susquehanna set a target price of $570.0 on 01/22/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.